NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the minimum stockholders' equity requirement of $2.5 million. Accordingly, the previously disclosed listing matter has been closed.
NanoVibronix, Inc.（纳斯达克股票代码：NAOV）（“公司”）是一家生产 UroShield 和 PainShield 表面声波 (SAW) 便携式超声治疗设备的医疗设备公司，今天宣布，该公司于 2023 年 11 月 20 日收到了纳斯达克股票市场有限责任公司的正式通知称，公司已证明符合在纳斯达克资本市场继续上市的所有适用标准，包括 250 万美元的最低股东权益要求。据此，此前披露的上市事宜已结束。
